SYDNEY: A groundbreaking Australian clinical trial has shown that a majority of melanoma patients whose cancer has spread to the brain can be cured with combination immunotherapy, reported Xinhua.
The Melanoma Institute Australia (MIA) on Tuesday (Feb 18) released seven-year follow-up results from a clinical trial that was conducted between 2014 and 2017, showing that long-term survival is achievable for advanced skin cancer patients.
